Cipla announces its entry into the weight management sector in India, as part of its strategy to diversify and strengthen its healthcare portfolio, revealed by CEO Umang Vohra in t...
Cipla announces a significant 30% increase in net profit and 9% revenue growth for Q4, with an 8% annual revenue rise to Rs 27,548 crore. Leadership remains optimistic about future...
Cipla partners with Taiwan's Formosa Pharmaceuticals to market clobetasol propionate ophthalmic suspension across 11 countries, aiming to improve post-operative recovery for ocular...
